Currently, Pavel Raifeld occupies the position of Chief Executive Officer of Innoviva, Inc. and Chief Executive Officer at Theravance Respiratory Co. LLC. Mr. Raifeld is also on the board of La Jolla Pharmaceutical Co. and Entasis Therapeutics Holdings, Inc.

Mr. Raifeld previously held the position of Senior Member-Healthcare Investment Banking at Credit Suisse Securities (USA) LLC.

Pavel Raifeld received an undergraduate degree from Harvard University and an MBA from The Trustees of Columbia University in The City of New York.